PlainPharmaWatch

CMS Open Payments · Program Year 2024

Scpharmaceuticals Inc.

Scpharmaceuticals Inc. reported $1,622,083.11 in payments to 13,366 physicians and teaching hospitals across 13,372 transactions.

See the rankings → How this is sourced
$1.6M
Total payments
13,372
Transactions
13,366
Recipients
+$342.2K
General Payments vs PY2023

Scpharmaceuticals Inc. reported $1,622,083.11 in payments to 13,366 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #500 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $121.36 per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Scpharmaceuticals Inc. pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#500
of 1,925 companies
0.0%
of all US industry payments
0.0%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Scpharmaceuticals Inc.'s CMS-reported General Payments increased by $342.2K (+53.6%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2023: SCPHARMACEUTICALS INC.PY2024: SCPHARMACEUTICALS INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$638.2KPY2024$980.4K
PY2023
$638,170.44
PY2024
$980,363.67

How Scpharmaceuticals Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Scpharmaceuticals Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,622,083 Top 26% higher than 74% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Scpharmaceuticals Inc.

Averaging $121.30 per transaction and $121.36 per recipient, Scpharmaceuticals Inc.'s Program Year 2024 total comes to $1,622,083.11 across 13,372 transactions and 13,366 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #500 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

125 transactions worth $380.4K make "Compensation for Services Other Than Consulting" the top general-payment category in the 6-category breakdown below, 23.5% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 6 types of general payments, Scpharmaceuticals Inc.'s largest category was "Compensation for Services Other Than Consulting" at $380.4K - 23.5% of the company's reported total.

How Scpharmaceuticals Inc. divides its payments

How the reported total splits across payment categories

1. Compensation for Services…$380.4K2. Food and Beverage$362.7K3. Honoraria$112.3K4. Space Rental or Facility …$53.2K5. Consulting Fee$44.6K6. Travel and Lodging$27.1K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $380.4K 125
Food and Beverage $362.7K 13,078
Honoraria $112.3K 16
Space Rental or Facility Fees $53.2K 18
Consulting Fee $44.6K 16
Travel and Lodging $27.1K 113

Recipient Concentration in General Payments

The five largest recipient relationships account for $195,456.35 (19.9%) of $980,363.67 in this company's General Payments records across 7,419 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Scpharmaceuticals Inc.

The five named recipients with the highest reported General Payments from this company

Billy Abraham$45.0KHunter Clay Champion Sr$44.3KDaniel Bensimhon$41.3KErika D Feller$36.1KVamsi Krishna$28.8K
  1. 1

    Billy Abraham

    $45,000.00 across 4 reported transactions

  2. 2

    Hunter Clay Champion Sr

    $44,291.86 across 18 reported transactions

  3. 3

    Daniel Bensimhon

    $41,250.93 across 25 reported transactions

  4. 4

    Erika D Feller

    $36,083.75 across 26 reported transactions

  5. 5

    Vamsi Krishna

    $28,829.81 across 49 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $121.30. Average per recipient: $121.36.

Total Amount

$1,622,083.11

Avg per Transaction

$121.30

Avg per Recipient

$121.36

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Scpharmaceuticals Inc. Share

0.0%

#500 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Scpharmaceuticals Inc.

Terumo Medical Corporation

$1.6M 6,609 recipients

Menarini Silicon Biosystems, Inc.

$1.6M 490 recipients

Endologix LLC

$1.6M 4,167 recipients

SmartPractice Allergen Bank, L.L.C.

$1.6M 4 recipients

Neuropace, Inc.

$1.6M 1,828 recipients

Zavation Medical Products, LLC

$1.6M 560 recipients

Frequently Asked Questions

How much did Scpharmaceuticals Inc. pay to physicians and hospitals in 2024? ▾
Scpharmaceuticals Inc. made $1,622,083.11 in payments to physicians and hospitals in Program Year 2024, across 13,372 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Scpharmaceuticals Inc.? ▾
Averaging $121.36 per recipient, Scpharmaceuticals Inc.'s 2024 payments reached 13,366 physicians and teaching hospitals.
What types of payments did Scpharmaceuticals Inc. make? ▾
6 categories of general payment make up Scpharmaceuticals Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Compensation for Services Other Than Consulting" at $380.4K, representing 23.5% of the company's reported total.
How does Scpharmaceuticals Inc. rank among pharmaceutical companies? ▾
Scpharmaceuticals Inc. ranks #500 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Scpharmaceuticals Inc.? ▾
The average transaction from Scpharmaceuticals Inc. was $121.30 in 2024. The company made 13,372 total transactions to 13,366 recipients.
Where does the payment data for Scpharmaceuticals Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Scpharmaceuticals Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.